The Safer Prescription of Opioids Tool USA Market feasibility study

SPOT -更安全的阿片类药物处方工具是一个新型的数字健康平台，作为软件即服务分发，已被证明可以显着提高阿片类药物处方的信心和遵守最佳实践指南。SPOT已被BBC报道，是SDI在2020年值得关注的12大数字健康创新之一。SPOT已被纳入苏格兰政府的冠状病毒19姑息治疗应对工具包。在最近的IUK项目之后，SPOT与英国和欧洲的专业出版发行商Class Professional Publishing合作。截至2021年4月，SPOT现已在其Salesforce平台上在欧洲范围内提供服务，并辅以一线销售和技术支持。基于过去两年建立的特定联系，我们在英国和欧洲市场的进展，以及COVID-19大流行带来的数字健康势头的增加，我们正寻求与已表示对SPOT有兴趣的美国潜在商业伙伴进行可行性研究。

SPOT - The Safer Prescription of Opioids Tool is a novel digital health platform, distributed as software as a service, which is proven to significantly improve the confidence of opioid prescribing and adherence to best practice guidelines. SPOT has been featured by the BBC and is one of SDI's top 12 Digital Health innovations to watch in 2020\. SPOT has been included in the Scottish Government's Coronavirus 19 palliative care response toolkit.Following a recent IUK project, SPOT has partnered with a UK and European-based professional publishing distributor, Class Professional Publishing. As of April 2021, SPOT is now available Europe-wide on their Salesforce platform, complemented with first-line sales and technical support.Building on specific contacts engendered over the last two years, our progress in the UK and European markets, and an increase in momentum for digital health from the COVID-19 pandemic, we seek to carry out a feasibility study with potential commercial partners in the USA who have already expressed interest in SPOT.